Chimeric antigen receptor (CAR)-modified natural killer (NK) cells show antileukemic activity
against acute myeloid leukemia (AML) in vivo. However, NK cell-mediated tumor killing is …

Immunotherapy has recently emerged as a promising therapeutic modality for the treatment
of various diseases such as cancer, inflammation, autoimmune diseases, and infectious …

Natural killer (NK) cells are cytotoxic lymphocytes that are critical for the innate immune
system. Engineering NK cells with chimeric antigen receptors (CARs) allows CAR-NK cells …

Viral infections persist as a significant cause of morbidity and mortality worldwide.
Conventional therapeutic approaches often fall short in fully eliminating viral infections …

Natural killer (NK) cells have high intrinsic cytotoxic capacity, and clinical trials have
demonstrated their safety and efficacy for adoptive cancer therapy. Expression of chimeric …

Natural killer (NK) cells are crucial in the innate immune response and show promise in
cancer immunotherapy, but face challenges in activation and targeted gene delivery. In this …

Background: Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with
a high relapse rate and still limited therapeutic options. Natural killer (NK) cell-based …